Development of Applications of Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging – Year two

Funded through a series of NSERC partnership grants, Cubresa Inc. have been working with the applicants to develop technologies for pre-clinical imaging for positron emission tomography (PET) imaging and PET friendly radiofrequency (RF) coils for magnetic resonance imaging (MRI) of small animals. To date, our collaboration has played a direct role in Cubresa being the […]

Read More
Using PET/MRI to improve current pre-clinical biomarkers in cancer

Treatments that involve activating a patient’s own immune system, immunotherapies, are becoming important cancer therapies. Unfortunately, doctors don’t always know the best way to combine these therapies to best treat patients and the current tools they have to evaluate treatment success don’t work well for immunotherapies. Molecular imaging, particularly magnetic resonance imaging (MRI) or positron […]

Read More
Development of Applications of Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging

Funded through a series of NSERC partnership grants, Cubresa Inc. have been working with the applicants to develop technologies for pre-clinical imaging for positron emission tomography (PET) imaging and PET friendly radiofrequency (RF) coils for magnetic resonance imaging (MRI) of small animals. To date, our collaboration has played a direct role in Cubresa being the […]

Read More
PET/MRI Imaging Development for Pre-clinical Neuroimaging Applications

The field of nuclear medicine relies on positron emission tomography (PET) and single photon emission computed tomography (SPECT) scanners to visualize molecular processes in normal and disease states in the living human. These imaging technologies have significant potential to enhance our ability to diagnose disease, develop appropriate disease-modifying treatments and for non-invasive monitoring of these […]

Read More